COMIP‐001: A clinical 13‐antibody, 12‐color flow cytometry panel for optimized immunophenotyping of T/ <scp>NK</scp> cells in human leukemia and lymphoma diagnostics

The objective of this 12-color/13-antibody single-tube panel is to assist in the diagnosis of T/NK-cell leukemias and lymphomas. In the clinical setting, the absence of a standardized T/NK-cell panel limits inter-laboratory data comparability, contributes to diagnostic variability, and results in redundant efforts across laboratories to design and validate panels for flow cytometry. Developing and promoting a panel that allows for rapid and fairly comprehensive labeling of surface T/NK-cell markers, including the anti-T-cell receptor β-chain constant region 1 (TRBC1) antibody, will streamline the workflow by establishing a standard immunophenotyping T/NK-cell panel for detecting neoplastic T/NK cells and lay the foundation for future COMIPs.

Authors

Institutions

Publication Details

Journal
Cytometry Part B Clinical Cytometry
Published
2026-02-09
DOI
https://doi.org/10.1002/cytob.70015
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COMIP‐001: A clinical 13‐antibody, 12‐color flow cytometry panel for optimized immunophenotyping of T/ NK cells in human leukemia and lymphoma diagnostics

Nicole So, Sara A. Monaghan, K. T. Davis, Grant C. Bullock et al.
Cytometry Part B Clinical Cytometry
Immune Cell Function and Interaction
article

COMIP‐001: A clinical 13‐antibody, 12‐color flow cytometry panel for optimized immunophenotyping of T/ NK cells in human leukemia and lymphoma diagnostics

Nicole So, Sara A. Monaghan, K. T. Davis, Grant C. Bullock, Ahmad Al-Attar, Wendy Shallenberger
article en

Abstract

The objective of this 12-color/13-antibody single-tube panel is to assist in the diagnosis of T/NK-cell leukemias and lymphomas. In the clinical setting, the absence of a standardized T/NK-cell panel limits inter-laboratory data comparability, contributes to diagnostic variability, and results in redundant efforts across laboratories to design and validate panels for flow cytometry. Developing and promoting a panel that allows for rapid and fairly comprehensive labeling of surface T/NK-cell markers, including the anti-T-cell receptor β-chain constant region 1 (TRBC1) antibody, will streamline the workflow by establishing a standard immunophenotyping T/NK-cell panel for detecting neoplastic T/NK cells and lay the foundation for future COMIPs.

Cytometry Part B Clinical Cytometry
Tufts University (US), University of Iowa (US), University of Pittsburgh (US), UPMC Health System (US)
Partnerships for the goals
Openalex Percentile: Top 62%
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

COMIP‐001: A clinical 13‐antibody, 12‐color flow cytometry panel for optimized immunophenotyping of T/ <scp>NK</scp> cells in human leukemia and lymphoma diagnostics — Nicole So, Sara A. Monaghan, et al. · Cytometry Part B Clinical Cytometry (2026) | TGRS Research Map | TGRS